Psychedelics: From Cave Art to 21st-Century Medicine for Addiction
European Addiction Research · 2024
DOI: 10.1159/000540062 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Addiction Research, 2024. Verfasst von Ioanna A Vamvakopoulou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Brain Sciences, Centre for Psychiatry, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK, joanna.vamvakopoul…. Hauptthemen laut MEDLINE: Hallucinogens, Lysergic Acid Diethylamide, Substance-Related Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background: Psychedelic substance use in ritualistic and ceremonial settings dates back as early as 8,500 BCE. Only in recent years, from the mid-20th century, we have seen the re-emergence of psychedelics in a therapeutic setting and more specifically for the treatment of addiction. This article aims to review research over the past 40 years using classic (psilocybin, lysergic acid diethylamide [LSD], dimethyltryptamine [DMT], mescaline) and atypical (ketamine, ibogaine, 5-MeO-DMT, 3,4-methylenedioxymethamphetamine) psychedelics for the treatment of addiction. Summary: We will start with an overview of the pharmacology and physiological and psychological properties of psychedelic substances from pre-clinical and clinical research. We will then provide an overview of evidence gathered by studies conducted in controlled research environments and naturalistic and ceremonial settings, while we identify the proposed therapeutic mechanisms of each psychedelic substance. Key Messages: Classic and atypical psychedelics show promise as therapeutic alternatives for the treatment of addiction, through the improvement of psychological and physiological symptoms of dependence. A more comprehensive understanding of the ancient and present-day knowledge of the therapeutic potential of psychedelics can facilitate hope for psychedelic therapeutics in the treatment of addiction, especially for individuals who have failed other conventional treatment methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Brain Sciences, Centre for Psychiatry, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK, joanna.vamvakopoulou20@imperial.ac.uk.
- Division of Brain Sciences, Centre for Psychiatry, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK.
Zitieren
APA
Vamvakopoulou, I. A., & Nutt, D. J. (2024). Psychedelics: From Cave Art to 21st-Century Medicine for Addiction. European Addiction Research. https://doi.org/10.1159/000540062
Vancouver
Vamvakopoulou IA, Nutt DJ. Psychedelics: From Cave Art to 21st-Century Medicine for Addiction. European Addiction Research. 2024. doi:10.1159/000540062
BibTeX
@article{Vamvakopoulou2024,
author = {Vamvakopoulou, Ioanna A and Nutt, David J},
title = {Psychedelics: From Cave Art to 21st-Century Medicine for Addiction},
journal = {European Addiction Research},
year = {2024},
doi = {10.1159/000540062}
}
EUVIMED